Intervention not reported
Non‐fatal myocardial infarction Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower non‐fatal myocardial infarction Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Rehospitalisation due to heart failure Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in rehospitalisation due to heart failure Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Arrhythmias Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention may leads to lower arrhythmias Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
Composite MACE Long‐term · people with chronic ischaemic heart disease and congestive heart failure
The intervention showed no clear difference in composite MACE Long‐term (low certainty).
1 finding from 1 review
Intervention not reported
LVEF (%) measured by MRI Long‐term · people with chronic ischaemic heart disease and congestive heart failure
1 finding from 1 review
Intervention not reported
Cessation at longest · People who smoke
The intervention leads to higher cessation at longest (high certainty).
1 finding from 1 review
Intervention not reported
Cessation at longest · People who smoke
The intervention probably leads to higher cessation at longest (moderate certainty).
1 finding from 1 review
Pain (long‐term) VAS. Scale from: 0 to 10. · participants with acute or subacute low‐back pain
1 finding from 1 review
Disability Long‐term (≥ 12 months) Disability scores converted to 0 to 100 scale to allow for comparison of different disability scales (RMDQ, ODI, JOA) · participants with acute or subacute low‐back pain
1 finding from 1 review
Cannabis frequency · Substance‐using adolescents
1 finding from 1 review
Serious adverse events "Defined as events that result in death, hospitalization, prolongation of hospitalization, or are life threatening (based on the judgment of the study physician)" (Quinn 2010) · Apathy in people with mild‐to‐moderate Alzheimer's disease
Omega‐3 PUFA supplements showed no clear difference in serious adverse events "Defined as events that result in death,… compared with placebo (high certainty).
1 finding from 1 review
Symptoms relating to the breast (EORTC QLQ‐BR23): long‐term (≥ 8 weeks) · cancer patients
1 finding from 1 review
Bodily pain (SF‐8) ‐ long‐term (≥ 8 weeks) · cancer patients
1 finding from 1 review
Reported RPE use among farmers ‐ Long term · workers
It is very uncertain whether education changes reported RPE use among farmers ‐ Long term compared with no intervention (very low certainty).
1 finding from 1 review
Relapse · patients with schizophrenia
It is very uncertain whether CHLORPROMAZINE changes relapse: long term (over 12 months) compared with OLANZAPINE (very low certainty).
1 finding from 1 review
Function (all scores/instruments): long term Scale from: 0 to 100; higher scores = better function. · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes function (all scores/instruments): long term Scale from: 0 to 100;… compared with microfracture (very low certainty).
1 finding from 1 review
QoL · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes quality of life: long‐term KOOS QOL score. Scale 0 to 100; higher… compared with microfracture (very low certainty).
1 finding from 1 review
Failure of treatment and adverse effects: long‐term Participants with surgery and symptom recurrence · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes failure of treatment and adverse effects: long‐term Participants… compared with microfracture (very low certainty).
1 finding from 1 review
Pain North Americal Spine Society pain scores. Scale from: 0 to 100 (higher scores indicate less pain). · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes pain: long‐term KOOS Pain score. Scale 0 to 100; higher scores =… compared with microfracture (very low certainty).
1 finding from 1 review
Activity: long term (5 or more years · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes activity: long term (5 or more years compared with microfracture (very low certainty).
1 finding from 1 review